Scarica l'app Stockscreener
6.25
0.95%
-0.06
Dopo l'orario di chiusura:
6.28
0.03
+0.48%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TPST Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.31
Aprire:
$6.36
Volume 24 ore:
29,028
Relative Volume:
0.27
Capitalizzazione di mercato:
$23.02M
Reddito:
-
Utile/perdita netta:
$-31.11M
Rapporto P/E:
-4.085
EPS:
-1.53
Flusso di cassa netto:
$-28.18M
1 W Prestazione:
-6.30%
1M Prestazione:
-8.76%
6M Prestazione:
-47.95%
1 anno Prestazione:
-74.15%
Intervallo 1D:
$6.22
$6.39
Intervallo di 1 settimana:
$6.20
$6.7999
Portata 52W:
$5.3495
$28.34
Tempest Therapeutics Inc Stock (TPST) Company Profile
Nome
Tempest Therapeutics Inc
Settore
Industria
Telefono
415-798-8589
Indirizzo
2000 SIERRA POINT PARKWAY, BRISBANE
Confronta TPST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
6.25 | 23.24M | 0 | -31.11M | -28.18M | -1.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-08 | Iniziato | Jefferies | Buy |
Tempest Therapeutics Inc Borsa (TPST) Ultime notizie
Is Tempest Therapeutics Inc. a good long term investmentSuperior stock growth - Autocar Professional
Tempest Therapeutics Inc. Stock Analysis and ForecastExplosive wealth accumulation - jammulinksnews.com
What analysts say about Tempest Therapeutics Inc. stockBreakout stock performance - jammulinksnews.com
What drives Tempest Therapeutics Inc. stock priceTriple-digit wealth increases - Autocar Professional
Is Tempest Therapeutics Inc. stock a growth or value playSmart High Yield Swing Trades - Newser
Why Tempest Therapeutics Inc. stock attracts strong analyst attentionPrecision Entry Strategy - Newser
How Tempest Therapeutics Inc. stock performs during market volatilityFree Real-Time Trading Opportunities - Newser
What makes Tempest Therapeutics Inc. stock price move sharplyFree Access to Community - Newser
Head-To-Head Contrast: Tempest Therapeutics (NASDAQ:TPST) vs. Relmada Therapeutics (NASDAQ:RLMD) - Defense World
Tempest Therapeutics (NASDAQ:TPST) Trading Up 0.2% – Here’s Why - Defense World
Tempest Therapeutics’ Promising Advances in Liver Cancer Treatment - TipRanks
Tempest Receives Clearance to Proceed with Pivotal Trial of - GlobeNewswire
Millennium Management LLC Acquires Shares of 189,506 Tempest Therapeutics, Inc. (NASDAQ:TPST) - Defense World
Tempest Therapeutics Secures $4.1M in Direct Offering - TipRanks
SEC Form 424B5 filed by Tempest Therapeutics Inc. - Quantisnow
Form 424B5 Tempest Therapeutics, - StreetInsider
Tempest Therapeutics Announces $4.6 Mln Registered Direct Offering With Institutional Investor - Nasdaq
Tempest Therapeutics (TPST) Announces New Stock Purchase Agreeme - GuruFocus
Tempest Therapeutics ends ATM prospectus with Jefferies By Investing.com - Investing.com Canada
Tempest Announces $4.6 Million Registered Direct Offering of Common Stock - The Manila Times
Tempest Therapeutics, Inc. Announces $4.6 Million Registered Direct Offering of Common Stock - Nasdaq
Tempest Therapeutics announces $4.6 million registered direct offering - Investing.com
Tempest Therapeutics ends ATM prospectus with Jefferies - Investing.com
Tempest Therapeutics Terminates ATM Prospectus Supplement Dated February 6, 2025SEC Filing - MarketScreener
Tempest Therapeutics Raises $4.6M From Single Institutional Investor: Strategic Alternative Process Funded - Stock Titan
Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: KLTO, TPST, PYPD, MOVE... - RTTNews
Tempest Therapeutics Shifts Executives to Consulting Roles - TipRanks
Tempest Therapeutics stock rises on EMA Orphan Drug Designation By Investing.com - Investing.com South Africa
Tempest Therapeutics stock rises on EMA Orphan Drug Designation - Investing.com
Tempest Therapeutics Inc Azioni (TPST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.91%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):